This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Fundacio Institut Catala D'investigacio Quimica (Iciq), The United States of America, as Represented by the Secretary, Department of Health and Human Services, Universitat Rovira I Virgili. Active years: 2019.
Company Filing History:
1 out of 8 
1 out of 3,690 
1 out of 10 
Years Active: 2019
Title: Laura Lopez: Innovator in Cancer and Diabetes Treatment
Introduction
Laura Lopez is a prominent inventor based in Barcelona, Spain. She has made significant contributions to the field of medical research, particularly in the development of compounds that can aid in the treatment of serious health conditions such as cancer and diabetes. Her innovative work has garnered attention and respect within the scientific community.
Latest Patents
Laura Lopez holds 1 patent for her invention titled "Epoxyazulene derivatives useful for treating cancer and diabetes." This patent discloses a compound of formula (I), where R-Rand X are defined as described in her research. The patent also outlines methods for utilizing this compound, including specific approaches for treating cancer and diabetes.
Career Highlights
Throughout her career, Laura has worked with esteemed institutions, including Universitat Rovira I Virgili. She has also collaborated with The United States of America, as represented by the Secretary, Department of Health and Human Services. Her work in these organizations has allowed her to advance her research and contribute to significant medical advancements.
Collaborations
Laura has collaborated with notable professionals in her field, including Fernando Bravo and John A Beutler. These partnerships have enriched her research and expanded the impact of her innovations.
Conclusion
Laura Lopez is a dedicated inventor whose work in developing treatments for cancer and diabetes showcases her commitment to improving health outcomes. Her contributions to medical research are invaluable and highlight the importance of innovation in addressing critical health challenges.